ArticleOpen medicine (Warsaw, Poland)2026
Correlation analysis of pituitary sagittal height, anterior posterior diameter, coronal width, and pituitary stalk abnormalities with dwarfism based on MRI measurement.
Article in Open medicine (Warsaw, Poland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Based on MRI examination, to explore the relationship between pituitary sagittal height (PSH), anterior posterior diameter (APD), coronal width (CW), and pituitary stalk abnormalities (PSA) and short stature. Methods: A retrospective study was performed on 257 children with suspected short stature admitted to hospitals from January 2020 to January 2024. Clinical data of the patient were collected, and MRI was used to measure the patient's PSH, APD, CW, and PSA. Spearman correlation analysis and ROC curve analysis were used to verify the relationship between PSH, APD, CW, and PSA, and short stature, as well as their predictive performance for short stature. Positive cases are defined as children diagnosed with short stature who appear 2 standard deviations (<-2SD) or less below average height for their age and sex in height measurements accompanied by abnormal growth hormone levels. In contrast, negative cases are those children whose height is within the normal range, that is, height not less than 2 standard deviations (>-2SD) below the average height for their age and sex, and whose growth hormone levels are within the normal range. Results: The GH peak values of<-2SD group, -2SD-3SD group, and >-3SD group, were 7.16 (4.58, 10.03) ng mL Conclusions: Pituitary APD, CW, and PSA are not associated with short stature, while PSH is associated with short stature. There is an obvious difference in PSH between children with non-short stature and those with short stature, but the role of PSH in predicting short stature and distinguishing short stature types is relatively poor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.